Papillon–Lefèvre syndrome
Papillon–Lefèvre syndrome (PLS) is a rare genetic disorder characterized by severe periodontitis leading to premature loss of both primary and permanent teeth, and hyperkeratosis of the palms and soles. It is caused by mutations in the cathepsin C gene.
Symptoms[edit | edit source]
The primary symptoms of Papillon–Lefèvre syndrome include:
- Periodontitis: This is often the first sign of PLS, usually appearing between the ages of 1 and 4. It leads to inflammation of the gums and eventual loss of teeth.
- Hyperkeratosis: This involves thickening of the skin on the palms of the hands and soles of the feet. It typically develops during the first few years of life.
Causes[edit | edit source]
Papillon–Lefèvre syndrome is caused by mutations in the cathepsin C gene. This gene provides instructions for making a protein that is involved in the immune system. Mutations in this gene lead to a reduction in the activity of the cathepsin C protein, which impairs the immune system's ability to fight off bacteria in the mouth, leading to periodontitis.
Diagnosis[edit | edit source]
Diagnosis of Papillon–Lefèvre syndrome is based on the clinical symptoms, particularly the presence of severe periodontitis and hyperkeratosis. Genetic testing can confirm a diagnosis by identifying mutations in the cathepsin C gene.
Treatment[edit | edit source]
Treatment for Papillon–Lefèvre syndrome primarily involves managing the symptoms. This may include:
- Regular dental cleanings and use of antibacterial mouth rinses to manage periodontitis.
- Use of emollients and keratolytic agents to manage hyperkeratosis.
- Antibiotic therapy to treat any associated infections.
Prognosis[edit | edit source]
With appropriate management, individuals with Papillon–Lefèvre syndrome can lead normal lives. However, the loss of teeth can affect nutrition and speech, and the skin symptoms can cause discomfort and social stigma.
See also[edit | edit source]
Papillon–Lefèvre syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD